Seizures
213
27
32
127
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
36 trials with published results (17%)
Research Maturity
127 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.0%
17 terminated out of 213 trials
88.2%
+1.6% vs benchmark
22%
47 trials in Phase 3/4
28%
36 of 127 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 127 completed trials
Clinical Trials (213)
Investigating Epilepsy: Screening and Evaluation
Cholinergic Enhancement of Theta
Modulating Movement Intention Via Cortical Stimulation
Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
Glioblastoma Remote Monitoring and Care - Research Protocol
RNS System LGS Feasibility Study
Neural Circulatory Control and SUDEP Risk.
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Predisposing Factors for Post-stroke Epilepsy
Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
BHV-7000 Responsive Neurostimulation System (RNS) Study
A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy